A clinical trial including endometrial cancer patients reported that a ketogenic diet (70% fat, 25% protein and 5% carbohydrate, no calorie restriction implemented) was found to have beneficial effects for a range of features, which included reduced central obesity and serum insulin, and increased physical function [44,45]. This evidence concerns the gene INS and Abdominal obesity.